HANS REICHENBACH

756 total citations
8 papers, 620 citations indexed

About

HANS REICHENBACH is a scholar working on Pharmacology, Organic Chemistry and Oncology. According to data from OpenAlex, HANS REICHENBACH has authored 8 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 2 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in HANS REICHENBACH's work include Microbial Natural Products and Biosynthesis (5 papers), Cancer Treatment and Pharmacology (2 papers) and Algal biology and biofuel production (2 papers). HANS REICHENBACH is often cited by papers focused on Microbial Natural Products and Biosynthesis (5 papers), Cancer Treatment and Pharmacology (2 papers) and Algal biology and biofuel production (2 papers). HANS REICHENBACH collaborates with scholars based in Germany. HANS REICHENBACH's co-authors include Klaus Gerth, GERHARD HÖFLE, Herbert Irschik, Gerhard Höfle, Florenz Sasse, J. R. HEIL, Heinrich Steinmetz, Norbert Bedorf, Dietmar Schummer and Rolf Jansen and has published in prestigious journals such as The Journal of Antibiotics.

In The Last Decade

HANS REICHENBACH

8 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
HANS REICHENBACH Germany 8 299 287 242 158 104 8 620
GERHARD HÖFLE Germany 8 268 0.9× 247 0.9× 228 0.9× 132 0.8× 54 0.5× 10 554
TOMIO TAKEUCHI Japan 16 208 0.7× 411 1.4× 332 1.4× 114 0.7× 79 0.8× 37 793
HEINRICH H. PETER Switzerland 18 266 0.9× 273 1.0× 315 1.3× 108 0.7× 73 0.7× 34 786
Morita Iwami Japan 18 213 0.7× 453 1.6× 257 1.1× 136 0.9× 71 0.7× 31 825
Makoto Yoshihama Japan 17 214 0.7× 398 1.4× 191 0.8× 78 0.5× 98 0.9× 34 769
Hayamitsu Adachi Japan 16 147 0.5× 440 1.5× 327 1.4× 61 0.4× 41 0.4× 53 746
Halina Pietraszkiewicz United States 13 171 0.6× 218 0.8× 264 1.1× 179 1.1× 45 0.4× 16 564
Jacob Gubbens Netherlands 14 232 0.8× 493 1.7× 123 0.5× 94 0.6× 28 0.3× 15 683
Christoph Mahlert Germany 13 390 1.3× 525 1.8× 131 0.5× 106 0.7× 93 0.9× 20 672
Taiji Inui Japan 16 258 0.9× 472 1.6× 269 1.1× 64 0.4× 192 1.8× 47 864

Countries citing papers authored by HANS REICHENBACH

Since Specialization
Citations

This map shows the geographic impact of HANS REICHENBACH's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HANS REICHENBACH with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HANS REICHENBACH more than expected).

Fields of papers citing papers by HANS REICHENBACH

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HANS REICHENBACH. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HANS REICHENBACH. The network helps show where HANS REICHENBACH may publish in the future.

Co-authorship network of co-authors of HANS REICHENBACH

This figure shows the co-authorship network connecting the top 25 collaborators of HANS REICHENBACH. A scholar is included among the top collaborators of HANS REICHENBACH based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HANS REICHENBACH. HANS REICHENBACH is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gerth, Klaus, Heinrich Steinmetz, Gerhard Höfle, & HANS REICHENBACH. (2001). Studies on the Biosynthesis of Epothilones. The PKS and Epothilone C/D Monooxygenase.. The Journal of Antibiotics. 54(2). 144–148. 32 indexed citations
2.
Gerth, Klaus, Heinrich Steinmetz, Gerhard Höfle, & HANS REICHENBACH. (2000). Studies on the Biosynthesis of Epothilones: The Biosynthetic Origin of the Carbon Skeleton.. The Journal of Antibiotics. 53(12). 1373–1377. 40 indexed citations
3.
Sasse, Florenz, et al.. (2000). Tubulysins, New Cytostatic Peptides from Myxobacteria Acting on Microtubuli. Production, Isolation, Physico-chemical and Biological Properties.. The Journal of Antibiotics. 53(9). 879–885. 216 indexed citations
4.
Irschik, Herbert, Rolf Jansen, Klaus Gerth, Gerhard Höfle, & HANS REICHENBACH. (1995). Antibiotics from gliding bacteria. No.62. Disorazol A, an Efflcient Inhibitor of Eukaryotic Organisms Isolated from Myxobacteria.. The Journal of Antibiotics. 48(1). 31–35. 55 indexed citations
6.
Irschik, Herbert, Dietmar Schummer, Klaus Gerth, Gerhard Höfle, & HANS REICHENBACH. (1995). Antibiotics from gliding bacteria. No.60. The Tartrolons, New Boron-containing Antibiotics from a Myxobacterium, Sorangium cellulosum.. The Journal of Antibiotics. 48(1). 26–30. 72 indexed citations
7.
Gerth, Klaus, Dietmar Schummer, GERHARD HÖFLE, Herbert Irschik, & HANS REICHENBACH. (1995). Ratjadon: A New Antifungal Compound from Sorangium cellulosum (Myxobacteria) Production, Physico-chemical and Biological Properties.. The Journal of Antibiotics. 48(9). 973–976. 41 indexed citations
8.
Gerth, Klaus, Norbert Bedorf, Herbert Irschik, GERHARD HÖFLE, & HANS REICHENBACH. (1994). The soraphens: A family of novel antifungal compounds from Sorangium cellulosum (myxobacteria). I. Soraphen A1.ALPHA.: Fermentation, isolation, biological properties.. The Journal of Antibiotics. 47(1). 23–31. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026